Matteo Mombelli

ORCID: 0000-0003-3628-4247
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cytomegalovirus and herpesvirus research
  • Hepatitis C virus research
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Viral gastroenteritis research and epidemiology
  • Polyomavirus and related diseases
  • Antibiotic Use and Resistance
  • SARS-CoV-2 and COVID-19 Research
  • Adenosine and Purinergic Signaling
  • Histone Deacetylase Inhibitors Research
  • Hepatitis B Virus Studies
  • Antifungal resistance and susceptibility
  • HIV/AIDS drug development and treatment
  • Tuberculosis Research and Epidemiology
  • Bartonella species infections research
  • Autoimmune and Inflammatory Disorders
  • Salmonella and Campylobacter epidemiology
  • Healthcare Systems and Technology
  • vaccines and immunoinformatics approaches
  • Gut microbiota and health
  • Healthcare cost, quality, practices
  • Bacterial Infections and Vaccines
  • Peptidase Inhibition and Analysis
  • Clostridium difficile and Clostridium perfringens research

Ente Ospedaliero Cantonale
2025

Ospedale Regionale di Locarno
2024

University of Lausanne
2010-2023

University Hospital of Lausanne
2010-2016

Immunocompromised patients may be at increased risk for complications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However, comprehensive data SARS-CoV-2 infection in solid organ transplant (SOT) recipients are still lacking. We performed a multicenter nationwide observational study within the Swiss Transplant Cohort Study (STCS) to describe epidemiology, clinical presentation, treatment and outcomes first microbiologically documented among SOT recipients....

10.1111/ajt.16062 article EN cc-by-nc-nd American Journal of Transplantation 2020-05-16

Abstract Short chain fatty acids (SCFAs) produced by intestinal microbes mediate anti-inflammatory effects, but whether they impact on antimicrobial host defenses remains largely unknown. This is of particular concern in light the attractiveness developing SCFA-mediated therapies and considering that SCFAs work as inhibitors histone deacetylases which are known to interfere with defenses. Here we show propionate, one main SCFAs, dampens response innate immune cells microbial stimulation,...

10.1038/srep37944 article EN cc-by Scientific Reports 2016-11-29
Laura N. Walti Catrina Mugglin Matteo Mombelli Oriol Manuel Hans H. Hirsch and 93 more Nina Khanna Nicolas J. Mueller Christoph Berger Katia Boggian Christian Garzoni Dionysios Neofytos Christian van Delden Mirjam Mäusezahl Cédric Hirzel Patrizia Amico John‐David Aubert Vanessa Banz Sonja Beckmann Guido Beldi Christoph Berger Ekaterine Berishvili Annalisa Berzigotti Isabelle Binet Pierre‐Yves Bochud Sandra Branca Heiner C. Bucher Emanuelle Catana Anne Cairoli Yves Chalandon Sabina De Geest Olivier de Rougemont Sophie De Seigneuex Michael Dickenmann Joëlle Lynn Dreifuss Michel Duchosal Thomas Fehr Sylvie Ferrari‐Lacraz Christian Garzoni Déla Golshayan Nicolas Goossens Fadi Haidar Jörg Halter Dominik Heim Christoph Hess Sven Hillinger Hans H. Hirsch Patricia Hirt Günther F.L. Hofbauer Uyen Huynh‐Do Franz Immer Michael Koller Mirjam Laager Bettina Laesser Frédéric Lamoth Roger Lehmann Alexander Leichtle Oriol Manuel Hans‐Peter Marti Michele Martinelli Valérie A. McLin Katell Mellac Aurélia Mercay Karin Mettler A Müller Nicolas Müller Ulrike Müller-Arndt Beat Müllhaupt Mirjam Nägeli Graziano Oldani Manuel Pascual Jakob Passweg Rosemarie Pazeller Klara M. Posfay‐Barbe Juliane Rick Anne Rosselet Simona Rossi Silvia Rothlin Frank Ruschitzka Thomas Schachtner Urs Schranz Stefan Schaub Alexandra Scherrer Aurelia Schnyder Macé M. Schuurmans Simon Schwab Thierry Sengstag Federico Simonetta Susanne Stampf Jürg Steiger Guido Stirnimann Ueli Stützinger Christian van Delden Jean-Pierre Venetz Jean Villard Julien Vionnet Madelaine Wick Markus J. Wilhelm Patrick Yerly

Vaccine responses are decreased in solid organ transplant (SOT) recipients, and given the complexity of implementation, vaccination programs may be suboptimal. The actual burden vaccine-preventable infections (VPIs) among SOT recipients remains unclear.To assess incidence rate VPIs to evaluate whether at increased risk for specific compared with general population.This nationwide cohort study used data from Swiss Transplant Cohort Study on individuals who underwent May 2008 June 2019...

10.1001/jamanetworkopen.2023.10687 article EN cc-by-nc-nd JAMA Network Open 2023-04-28
Oriol Manuel Mirjam Laager Cédric Hirzel Dionysios Neofytos Laura N. Walti and 95 more Gideon Höenger Isabelle Binet Aurelia Schnyder Susanne Stampf Michael Koller Matteo Mombelli Min Jeong Kim Matthias Hoffmann Katrin Koenig Christoph Hess Anne‐Valérie Burgener Pietro E. Cippà Kerstin Hübel Nicolas J. Mueller Daniel Sidler Suzan Dahdal Franziska Suter‐Riniker Jean Villard Andrea Zbinden Giuseppe Pantaleo Nasser Semmo Karine Hadaya Natalia Enríquez Pascal Meylan Marc Froissart Déla Golshayan Thomas Fehr Uyen Huynh‐Do Manuel Pascual Christian van Delden Hans H. Hirsch Peter Jüni Nicolas J. Mueller Patrizia Amico John‐David Aubert Vanessa Banz Sonja Beckmann Guido Beldi Christoph Berger Ekaterine Berishvili Annalisa Berzigotti Isabelle Binet Pierre‐Yves Bochud Sanda Branca Heiner C. Bucher Oriol Manuel Anne Cairoli Yves Chalandon Sabina De Geest Olivier de Rougemont Sophie de Seigneux Michael Dickenmann Joëlle Lynn Dreifuss Michel A. Duchosal Thomas Fehr Sylvie Ferrari-Lacraz Christian Garzoni Déla Golshayan Nicolas Goossens Fadi Haidar Jörg Halter Dominik Heim Christoph Hess Sven Hillinger Hans H. Hirsch Patricia Hirt Linard Hoessly Günther F.L. Hofbauer Uyen Huynh‐Do Franz Immer Michael Koller Bettina Laesser Frédéric Lamoth Roger Lehmann Alexander Leichtle Oriol Manuel Hans‐Peter Marti Michele Martinelli Valérie A. McLin Katell Mellac Aurélia Merçay Karin Mettler Nicolas J. Mueller Ulrike Müller-Arndt Beat Müllhaupt Mirjam Nägeli Graziano Oldani Manuel Pascual Jakob Passweg Rosemarie Pazeller Klara M. Posfay‐Barbe Juliane Rick Anne Rosselet Simona Rossi Silvia Rothlin

Abstract Background The use of assays detecting cytomegalovirus (CMV)–specific T cell–mediated immunity may individualize the duration antiviral prophylaxis after transplantation. Methods In this randomized trial, kidney and liver transplant recipients from 6 centers in Switzerland were enrolled if they CMV-seronegative with seropositive donors or CMV-seropositive receiving antithymocyte globulins. Patients to a based on immune monitoring (intervention) fixed (control). control group planned...

10.1093/cid/ciad575 article EN cc-by-nc-nd Clinical Infectious Diseases 2023-09-22

Histone deacetylases (HDACs) control gene expression by deacetylating histones and nonhistone proteins. HDAC inhibitors (HDACi) are powerful anticancer drugs that exert anti-inflammatory immunomodulatory activities. We recently reported a proof-of-concept study demonstrating HDACi increase susceptibility to bacterial infections in vivo. Yet, still little is known about the effects of on antimicrobial innate immune defenses. Here we show belonging different chemical classes inhibit at...

10.1093/infdis/jir553 article EN The Journal of Infectious Diseases 2011-09-16

Sirtuin 2 (SIRT2) is one of the seven members family NAD+-dependent histone deacetylases. Sirtuins target histones and non-histone proteins according to their subcellular localization, influencing various biological processes. SIRT2 resides mainly in cytoplasm regulates cytoskeleton dynamics, cell cycle metabolic pathways. As such, has been implicated pathogenesis neurodegenerative, metabolic, oncologic chronic inflammatory disorders. This motivated development SIRT2-directed therapies for...

10.3389/fimmu.2017.01037 article EN cc-by Frontiers in Immunology 2017-08-28

Abstract Background One of the main objective Antimicrobial Stewardship programmes (ASp) is optimization antibiotic use, reducing use broad spectrum antibiotics when unnecessary. In this context, close monitoring carbapenem consumption mandatory. Methods The CASAS Project started in January 2024 4 public Hospitals (for a total approximately 1000 beds) Southern Switzerland, region with low prevalence multi-drug-resistant bacteria (MDR) and treatments (CAR-T). An electronic alert was sent to...

10.1093/ofid/ofae631.1904 article EN cc-by Open Forum Infectious Diseases 2025-01-29

Posttransplant lymphoproliferative disorder (PTLD) is a serious complication of solid organ transplantation (SOT). Most PTLD cases are associated with Epstein-Barr virus (EBV) infection. The role antiviral prophylaxis or rituximab therapy for prevention in SOT recipients controversial. In nationwide cohort, we assessed the incidence, presentation, and outcome histologically proven PTLD. We included 4765 patients follow-up duration 23 807 person-years (py). Fifty-seven were identified; 39...

10.1111/ajt.16423 article EN cc-by-nc American Journal of Transplantation 2020-12-02

To describe the epidemiology and clinical presentation of central nervous system (CNS) infections in solid organ transplant (SOT) recipients current era transplantation.Patients from Swiss Transplant Cohort Study (STCS) transplanted between 2008 2018 were included with a median follow-up 3.8 years. Epidemiological, microbiological, data extracted STCS database patients' medical records. We calculated incidence rates 90-day survival CNS infection.Among 4762 patients, 42 episodes infection 41...

10.1016/j.jinf.2022.05.019 article EN cc-by-nc-nd Journal of Infection 2022-05-21

Solid organ transplant (SOT) recipients are exposed to respiratory viral infection (RVI) during seasonal epidemics; however, the associated burden of disease has not been fully characterized. We describe epidemiology and outcomes RVI in a cohort enrolling 3294 consecutive patients undergoing SOT from May 2008 December 2015 Switzerland. Patient allograft outcomes, diagnosed routine clinical practice were prospectively collected. Median follow-up was 3.4 years (interquartile range 1.61-5.56)....

10.1111/ajt.16383 article EN cc-by-nc-nd American Journal of Transplantation 2020-11-01

Abstract Background The immunogenicity of the standard influenza vaccine is reduced in solid-organ transplant (SOT) recipients, so new vaccination strategies are needed this population. Methods Adult SOT recipients from 9 clinics Switzerland and Spain were enrolled if they >3 months after transplantation. Patients randomized (1:1:1) to a MF59-adjuvanted or high-dose (intervention), (control), with stratification by organ time transplant. primary outcome was response rate, defined as...

10.1093/cid/ciad477 article EN cc-by-nc-nd Clinical Infectious Diseases 2023-08-16

Cytomegalovirus (CMV) disease has been associated with the development of chronic lung allograft dysfunction (CLAD) after transplantation. However, relevance CMV replication occurring discontinuation antiviral prophylaxis on CLAD not fully established. Patients who underwent transplantation during 2004-2014 were included. All patients received for 3-6 months, followed by monitoring first year post-transplantation (preemptive therapy). Risk factors assessed Cox models. A linear regression...

10.1111/tid.12893 article EN Transplant Infectious Disease 2018-03-31

Background. ABO-incompatible (ABOi) kidney transplantation (KT) expands the donor pool and may help to overcome organ shortage. Nonetheless, concerns about infectious complications associated with ABOi-KT have been raised. Methods. In a nationwide cohort (Swiss Transplant Cohort Study), we compared risk for among ABOi ABO-compatible (ABOc) renal transplant recipients. Infections needed fulfill rigorous, prespecified criteria be classified as clinically relevant. Unadjusted adjusted competing...

10.1097/tp.0000000000004109 article EN cc-by-nc-nd Transplantation 2022-04-01

Food-safety measures are recommended in solid organ transplant (SOT) recipients. However, the actual adherence of patients a real-life setting and impact on incidence foodborne infections remain largely unexplored. We performed survey among SOT recipients followed at our institution, aiming to evaluate their food-safety behavior. assessed microbiologically proven by chart review. One hundred ninety-seven (kidney = 117, lung 35, liver 29, heart 16) participated survey. Overall, 17.7%...

10.1111/ajt.15725 article EN cc-by-nc-nd American Journal of Transplantation 2019-11-25

OBJECTIVES To investigate differences in chest computed tomography (CT) and radiographs (CXRs) of Pneumocystis jirovecii pneumonia (PJP) between renal transplant recipients (RTRs) human immunodeficiency virus (HIV)-positive patients. METHODS From 2005 to 2012, 84 patients with PJP (RTR n = 24; HIV 60) were included this retrospective multicentre study. Written informed consent was obtained. CT scans CXRs recorded within 2 weeks after the onset symptoms. diagnosis confirmed either by...

10.4414/smw.2019.20130 article EN cc-by Schweizerische medizinische Wochenschrift 2019-10-03

Food-safety measures are recommended to solid organ transplant (SOT) recipients. However, the burden of foodborne infections in SOT recipients has not been established. We describe epidemiology and outcomes bacterial a nationwide cohort including 4405 Switzerland between 2008 2018. Participants were prospectively followed for median 4.2 years with systematic collection data on infections, patient graft-related outcomes. identified 151 episodes microbiologically confirmed occurring 1.6 (IQR...

10.1111/ajt.16831 article EN cc-by-nc-nd American Journal of Transplantation 2021-09-12

Aspergillus is a ubiquitary mold, with whom the human has often contact. Normally not pathogen for immunocompetent subject, but it can be source of infections in immunocompromised patient or persons structural pneumological pathologies. In other subjects elicit allergic reactions immunological response. These different pathologies are various and difficult to diagnose. We propose here view these

10.53738/revmed.2024.20.895.2126 article EN Revue Médicale Suisse 2024-01-01

Background: In solid-organ transplant (SOT) recipients, influenza is associated with significant morbidity and mortality, while the immunogenicity of standard vaccine reduced. New vaccination strategies are needed. Methods: this observer participant masked randomised clinical trial, adult SOT recipients from nine clinics in Switzerland Spain were enrolled if they at least three months after transplantation. Patients (1:1:1) using an interactive web-based response system stratification by...

10.2139/ssrn.4374080 preprint EN 2023-01-01
Coming Soon ...